USRE36606EExpiredUtility

Synergistic pharmaceutical compositions

21
Assignee: MASSA TECHNOLOGY S APriority: Jul 28, 1994Filed: Oct 7, 1998Granted: Mar 7, 2000
Est. expiryJul 28, 2014(expired)· nominal 20-yr term from priority
Inventors:Georges Chriki
A61K 31/57
21
PatentIndex Score
2
Cited by
18
References
15
Claims

Abstract

.[.A pharmaceutical composition comprises a synergistic combination of about 0.01-0.15% by wt. triamcinolone acetonide and about 0.04-0.3% by wt. halcinonide as active ingredients, in combination with a pharmaceutically acceptable carrier..]. .Iadd.A pharmaceutical composition comprises a synergistic combination of at least about 0.01% by wt. triamcinolone acetonide and at least about 0.01% by wt. halcinonide as active ingredients therein, in combination with a pharmaceutically acceptable carrier. .Iaddend.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A pharmaceutical composition comprising triamcinolone acetonide and halcinonide in synergistic and effective amounts in combination with a pharmaceutically acceptable carrier. 
     
     
       2. A pharmaceutical composition comprising about 0.1% triamcinolone acetonide and about 0.1% halcinonide in combination with a pharmaceutical carrier. 
     
     
       3. A pharmaceutical composition according to claim 1, wherein said pharmaceutically acceptable carrier is a topical cream. 
     
     
       4. A pharmaceutical composition comprising triamcinolone acetonide and halcinonide in synergistic and effective amounts in combination with one or more of petroleum jelly, lanoline, and lanet wax. 
     
     
       5. A pharmaceutical composition of claim 4, further comprising water. 
     
     
       6. A pharmaceutical composition comprising about 0.1% triamcinolone acetonide, about 0.1% halcinonide, about 45 to 50% vaseline, about 6.5 to 7.5% lanoline, about 12 to 15% lanet wax, and a remainder of water, wherein, the percent values are characterized by weight. 
     
     
       7. A method for treating psoriasis in a patient comprising topically administering a composition of claim 1. 
     
     
       8. A method for treating psoriasis in a patient comprising topically administering a composition of claim 4. 
     
     
       9. A method for treating psoriasis in a patient comprising topically administering a composition of claim 6. 
     
     
       10. A method for treating dermatitis in a patient comprising topically administering a composition of claim 1. 
     
     
       11. A method for treating dermatitis in a patient comprising topically administering a composition of claim 4. 
     
     
       12. A method for treating dermatitis in a patient comprising topically administering a composition of claim 6. 
     
     
       13. A method for treating eczema in a patient comprising topically administering a composition of claim 1. 
     
     
       14. A method for treating eczema in a patient comprising topically administering a composition of claim 4. 
     
     
       15. A method for treating eczema in a patient comprising topically administering a composition of claim 6.

Join the waitlist — get patent alerts

Track USRE36606E — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.